Specific Changes in Immune System Components Predict Likelihood of Fungal Infection in Allogeneic Stem Cell Transplants (10/27/2008)


Injection of Umbilical Cord Stem Cells into Bone Appears Promising for Leukemia (8/12/2008)
The injection of stem cells collected from umbilical cords into the pelvic bone of patients with leukemia appears promising; however, longer follow-up is necessary to determine outcomes for these patients. These results were recently published in an early online publication of the Lancet Oncology.

Statins May Reduce Acute Graft-versus-host Disease (6/18/2008)
Researchers from Ohio State University have reported that statins may reduce the risk of developing acute graft-versus-host disease (GVHD) among patients who undergo allogeneic stem cell transplants. These results were reported at the 2008 annual meeting of the American Society of Clinical Oncology in Chicago, May 30-June 2.

Stem Cell Transplant Procedures Vary Throughout the World (5/9/2008)
Stem cell transplant practices vary substantially among physicians treating adults and children with hematologic malignancies (cancers of the blood or bone marrow such as leukemias and lymphomas).  These findings were published in the Journal of Clinical Oncology.

Use of Antifungal Agents Decreases Death in Allogeneic Stem Cell Transplants (12/4/2007)
According to an article recently published in the Journal of Clinical Oncology, preventive use of antifungal agents improves survival among patients undergoing an allogeneic stem cell transplant.

More Stem Cell Transplant News »

Stem Cell Transplant Procedures Vary Throughout the World (5/9/2008)
Stem cell transplant practices vary substantially among physicians treating adults and children with hematologic malignancies (cancers of the blood or bone marrow such as leukemias and lymphomas).  These findings were published in the Journal of Clinical Oncology.

MCP Chemotherapy Regimen May Reduce Amount of Stem Cells Collected in Follicular Lymphoma (2/1/2007)
According to results recently published in Annals of Oncology, the chemotherapy regimen consisting of melphalan, chlorambucil, and prednisone (MCP) appears to interfere with the ability to collect enough stem cells for an autologous stem cell transplant in patients with follicular non-Hodgkin’s lymphoma (NHL).

At-home Stem Cell Transplantation Reduces Cost and Hospital Time (10/26/2006)
According to an article recently published in the Journal of Clinical Oncology, at-home treatment for an autologous stem cell transplant reduces medical cost and hospital stay among patients with hematologic (blood) malignancies.

Presence of Cancer Cells in Circulating Blood Predicts Worse Outcomes After High-dose Therapy in Breast Cancer (8/1/2006)
According to an article recently published in the Journal of Clinical Oncology, the presence of small amounts of cancer cells in circulating blood as detected by a gene panel predicts a 300% increased risk of death among women with early breast cancer who undergo high-dose therapy and a stem cell transplant.

Certain Variables Predict Risk of Secondary Leukemia After Stem Cell Transplant (7/31/2006)
According to an article recently published in the Journal of Clinical Oncology, patients diagnosed with lymphoma who were previously treated with radiation therapy, those treated with four or more chemotherapy regimens, and those who take five days to collect enough stem cells for a transplant are at a higher risk of developing myelodysplastic syndromes or acute myeloid leukemia associated with a stem cell transplant.

More Stem Cell Transplant - Autologous Stem Cell Transplant News »

Specific Changes in Immune System Components Predict Likelihood of Fungal Infection in Allogeneic Stem Cell Transplants (10/27/2008)


Injection of Umbilical Cord Stem Cells into Bone Appears Promising for Leukemia (8/12/2008)
The injection of stem cells collected from umbilical cords into the pelvic bone of patients with leukemia appears promising; however, longer follow-up is necessary to determine outcomes for these patients. These results were recently published in an early online publication of the Lancet Oncology.

Statins May Reduce Acute Graft-versus-host Disease (6/18/2008)
Researchers from Ohio State University have reported that statins may reduce the risk of developing acute graft-versus-host disease (GVHD) among patients who undergo allogeneic stem cell transplants. These results were reported at the 2008 annual meeting of the American Society of Clinical Oncology in Chicago, May 30-June 2.

Stem Cell Transplant Procedures Vary Throughout the World (5/9/2008)
Stem cell transplant practices vary substantially among physicians treating adults and children with hematologic malignancies (cancers of the blood or bone marrow such as leukemias and lymphomas).  These findings were published in the Journal of Clinical Oncology.

Use of Antifungal Agents Decreases Death in Allogeneic Stem Cell Transplants (12/4/2007)
According to an article recently published in the Journal of Clinical Oncology, preventive use of antifungal agents improves survival among patients undergoing an allogeneic stem cell transplant.

More Stem Cell Transplant - Allogeneic Stem Cell Transplant News »